Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1998
10/28/1998EP0874054A2 Vector for the expression of immunoglobulin-cytokine fusionproteins in malignant B Cells
10/28/1998EP0874053A2 3-Dehydroquinate synthase (aroB)
10/28/1998EP0874051A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines.
10/28/1998EP0874050A2 Integrin ligand ITGL-TSP
10/28/1998EP0874049A1 Nucleic acid sequences of CIITA genes
10/28/1998EP0874048A2 Human hedgehog protein
10/28/1998EP0874047A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
10/28/1998EP0874046A1 A novel signal transduction factor and a gene encoding the same
10/28/1998EP0874045A1 Novel dnas and process for producing proteins by using the same
10/28/1998EP0873999A1 Antibody to the prorenin profragment, renin-active substance containing the same and prorenin assay reagent using the same
10/28/1998EP0873998A2 Receptor protein and its use
10/28/1998EP0873491A1 Ceramic packing with channels for thermal and catalytic beds
10/28/1998EP0873423A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy
10/28/1998EP0873417A1 Compositions for the detection of proteases in biological samples and methods of use thereof
10/28/1998EP0873415A1 Fusion protein delivery system and uses thereof
10/28/1998EP0873409A1 Equine rhinovirus 1 proteins
10/28/1998EP0873408A1 Calcium binding proteolipid compositions and methods
10/28/1998EP0873407A1 Apo-2 ligand
10/28/1998EP0873406A2 Protein induced by deprenyl
10/28/1998EP0873404A1 Angiotensin converting enzyme inhibitors
10/28/1998EP0873401A1 Novel retrovirus and diagnostic methods
10/28/1998EP0873399A1 Monoclonal lymphocytes and methods of use
10/28/1998EP0873361A2 Nuclear receptor ligands and ligand binding domains
10/28/1998EP0873360A1 Transforming growth factor alpha hiii
10/28/1998EP0873359A1 Regulator of cell proliferation
10/28/1998EP0873358A2 Capturing of microorganisms using complement components
10/28/1998EP0873357A2 Antithrombotic agents and methods of use
10/28/1998EP0873354A1 Novel amp activated protein kinase
10/28/1998EP0873353A1 IgG SEPARATION MEDIUM AND NOVEL PROTEIN A VARIANT
10/28/1998EP0873350A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3
10/28/1998EP0873349A1 Endothelial-monocyte activating polypeptide iii
10/28/1998EP0873348A1 Human vascular endothelial growth factor 3
10/28/1998EP0873141A1 Compositions and methods for therapeutic use
10/28/1998EP0873138A2 Improved pharmaceutical compositions
10/28/1998EP0873135A1 Peanut allergens and methods
10/28/1998EP0873132A1 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO
10/28/1998EP0873049A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains
10/28/1998EP0605484B1 Peptides having growth hormone releasing activity
10/28/1998EP0587719B1 DETECTION OF COLLAGEN DEGRADATION $i(IN VIVO)
10/28/1998EP0407392B2 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
10/28/1998CN1197483A Inducible herbicide resistance
10/28/1998CN1197461A Truncated glial cell line-derived neurotrophic factor
10/28/1998CN1197460A Cyclic peptide analogs of somatostatin
10/28/1998CN1197393A Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
10/28/1998CN1197392A Prepn. of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
10/28/1998CN1197281A Plasma display panel device and method of fabricating the same
10/28/1998CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes
10/28/1998CN1196956A Influenza vaccine
10/28/1998CN1040432C Spiro piperdines derivatives and its prepn. and applications
10/28/1998CA2231746A1 A human sodium dependent phosphate transporter (ipt-1)
10/27/1998US5827934 Cytotoxic diphtheria toxin fragments
10/27/1998US5827826 Compositions of human endothelial cell growth factor
10/27/1998US5827825 Polypeptide from the condensation of variable hexa- or heptapeptides with peptides containing twelve to twenty units of leucine and/or norleucine, for treatment of respiratory disorders
10/27/1998US5827824 Protease-resistant thrombomodulin analogs
10/27/1998US5827821 Conformationally stabilized cell adhesion peptides
10/27/1998US5827818 Anticoagulants; administered by injections along with a carrier
10/27/1998US5827817 P-selectin ligand protein
10/27/1998US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid
10/27/1998US5827750 Human virus associated with chronic fatigue immune deficiency syndrome and assay therefore
10/27/1998US5827738 Sustainable chick cell line infected with Marek's disease virus
10/27/1998US5827737 Stable drosophila cell line
10/27/1998US5827735 Pluripotent mesenchymal stem cells and methods of use thereof
10/27/1998US5827734 Materials and methods for determining ob protein in a biological sample
10/27/1998US5827733 Growth differentiation factor-8 (GDF-8) and polynucleotides encoding same
10/27/1998US5827731 Anticoagulant
10/27/1998US5827730 Protein containing atleast one amino acid glycine subsituted by arginine at position 972 and such substitution interferes with signal transduction through insulin receptor substrate-1
10/27/1998US5827718 Lipase, microorganisms producing the lipase, method of producing the lipase and use of the lipase
10/27/1998US5827712 Culturing with a gene encoding a heat shock protein enhancing to produce a soluble transglutaminase
10/27/1998US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells
10/27/1998US5827703 Methods and composition for in vivo gene therapy
10/27/1998US5827696 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
10/27/1998US5827695 Detection of wheat fungal pathogens using the polymerase chain reaction
10/27/1998US5827694 Bovine, porcine, feline, rabbit interferons
10/27/1998US5827693 Expression of recombinant hemoglobin and hemoglobin variants in yeast
10/27/1998US5827692 Parasiticides against heartworm, elephantiasis
10/27/1998US5827691 Process for preparing a protein which inhibits metastasis of cancer
10/27/1998US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/27/1998US5827688 Secreted proteins and polynucleotides encoding them
10/27/1998US5827686 Method of expressing genes in mammalian cells
10/27/1998US5827685 Methods and compositions of genetic stress response systems
10/27/1998US5827684 Production of Bacillus entomotoxins in methylotrophic yeast
10/27/1998US5827672 Human monocyte elastase inhibitor antibodies
10/27/1998US5827671 Antibodies raised against proteins of Leishmania which are expressed at an increased level in the amastigote form
10/27/1998US5827668 Immunodiagnostic assay for rheumatoid arthritis
10/27/1998US5827666 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
10/27/1998US5827659 Methods and apparatus for sequencing polymers using mass spectrometry
10/27/1998US5827655 Product of the mk3 gene; identifying immune response
10/27/1998US5827654 Basal body rod protein genes of campylobacter
10/27/1998US5827647 Treating samples with isolated empty parvovirus capsids, then detecting antigen-antibody complexes for diagnosis, also kits
10/27/1998US5827646 Comprising isolated epstein barr virus structural antigen and epstein barr nuclear antigen 1
10/27/1998US5827534 Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery
10/27/1998US5827519 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use
10/27/1998US5827518 Insect immunosuppressants; insecticides
10/27/1998US5827516 Decreasing major histocompatibility complex class ii antigen in mammal by introducing into antigen presenting cell an expression vector comprising a nucleic acid molecule coding for expression of peptide which binds to mhc class ii molecule
10/27/1998US5827515 Obtaining a dna segemnt containing spov dna sequence, introducing the segment into a bacillus thuringiensis host, isolating genetically engineered mutant capable of expressing exogenous crystal protein
10/27/1998US5827514 Pesticidal compositions
10/27/1998US5827073 Photoreactive peptide derivatives
10/27/1998CA2107216C Polyamino acid superabsorbents
10/27/1998CA2078694C Hepatitis b vaccine
10/27/1998CA2063721C Mycobacterium chelonae polar glycopeptidolipids-based immune booster medication